The transcription of the peroxisome proliferator-activated receptor α gene is regulated by protein kinase C

Toxicology Letters

Volumn 125, Issue 1-3, 2001, Pages 133-141

  Yaacob, Nik Soriani ^a,b   Norazmi, Mohd Nor ^c   Gibson, G Gordon ^c   Kass, George E N ^c  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^c NONE

Author keywords

Hepatocytes; Hypolipidaemic drugs; Peroxisome proliferators; PPAR; Tumours

Indexed keywords

ACYL COENZYME A OXIDASE; BISINDOLYLMALEIMIDE; CALPHOSTIN C; CIPROFIBRATE; CLOFIBRATE; FENOFIBRATE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PIRINIXIC ACID; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; LIVER CELL CULTURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CALCIUM; CELLS, CULTURED; GENE EXPRESSION REGULATION; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; PEROXISOME PROLIFERATORS; PROTEIN KINASE C; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0035976331     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(01)00433-7     Document Type: Article

References (46)

1. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription
2. Suppression of liver cell apoptosis in vitro by the nongenotoxic hepatocarcinogen and peroxisome proliferator nafenopin
3. Mitogenic actions of peroxisome proliferators: Involvement of protein kinase C and tumor necrosis factor α
4. Peroxisomal proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo
5. Potentiation of diacylglycerol-activated protein kinase C by acyl coenzyme A thioesters of hypolipemic drugs
6. Initiator-specific promotion of hepatocarcinogenesis by WY-14,643 and clofibrate
7. Positive regulation of the peroxisomal β-oxidation pathway by fatty acids through activation of peroxisome proliferator activated receptors (PPAR)
8. Nafenopin causes protein kinase C-mediated serine phosphorylation and loss of function of connexin 32 protein in rat hepatocytes without aberrant expression or localization
9. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
10. Staurosporine and calphostin C inhibit the phorbol ester-induced decrease of protein kinase C activity in rat hepatocytes
11. Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver
12. Peroxisome proliferators: Paradigms and prospects
13. Peroxisomal enzyme induction uncoupled from enhanced DNA-synthesis in putative preneoplastic liver foci of rats treated with a single dose of the peroxisome proliferator nafenopin
14. PPAR: A mediator of peroxisome proliferator action
15. Stimulation of the DNA binding activity of AP-1 by the peroxisome proliferator ciprofibrate and eicosanoids in cultured rat hepatocytes
16. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain
17. The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: Role of intracellular calcium
18. Roles of PPARs in health and disease
19. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
20. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C
21. Targeted disruption of the alpha-isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
22. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs
23. PPAR tissue distribution and interactions with other hormone signaling pathways
24. Regulation of the peroxisome proliferator-activated receptor-α gene by glucocorticoids
25. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in rats
26. Factors influencing peroxisome proliferation in cultured rat hepatocytes
27. Protein phosphorylation by peroxisome proliferators: Species-specific stimulation of protein kinases and its role in PP-induced transcriptional activation
28. The extracellular signal-regulated kinase pathway contributes to mitogenic and antiapoptotic effects of peroxisome proliferators in vitro
29. Palmitoyl-CoA and the acyl-CoA thioester of the carcinogenic peroxisome-proliferator ciprofibrate potentiate diacylglycerol-activated protein kinase C by decreasing the phosphatidylserine requirement of the enzyme
30. Phosphorylation of peroxisome proliferator-activated receptor alpha in Fao cells and stimulation by ciprofibrate
31. Role of PPARα in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643
32. Di(2-ethylhexyl)phthalate induces a functional zinc deficiency during pregnancy and teratogenesis that is independent of peroxisome proliferator-activated receptor α
33. Peroxisome proliferator-activated receptor α is restricted to hepatic parenchymal cells, not Kupffer cells: Implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis
34. Hepatocarcinogenesis of peroxisome proliferators
35. Peroxisome proliferator activate extracellular signal-regulated kinases in immortalized mouse liver cells
36. Role of Kupffer cells and oxidants in signaling peroxisome proliferator-induced hepatocyte proliferation
37. Diverse mechanisms of calcium mobilization by peroxisome proliferators in rat hepatocytes
38. Dexamethasone and insulin demonstrate marked and opposite regulation of the steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells: Hormonal modulation of fatty-acid-induced transcription
39. Regulation of peroxisome proliferator-activated receptor-α mRNA in rat liver
40. Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate
41. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging
42. The bisindolylmaleimide GF-109203X is a potent and selective inhibitor of protein kinase C
43. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene
44. Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis
45. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C
46. Use of competitive RT-PCR in the molecular analysis of peroxisome proliferation